Exact Mass: 467.1878674000001

Exact Mass Matches: 467.1878674000001

Found 465 metabolites which its exact mass value is equals to given mass value 467.1878674000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

O-Ethyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]carbamate

(2S,3S,4R,5R,6S)-4,5-bis(acetyloxy)-6-(4-{[(ethoxycarbonyl)amino]methyl}phenoxy)-2-methyloxan-3-yl acetate

C22H29NO10 (467.17913740000006)

O-Ethyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]carbamate is a fully acetylated carbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables.

N-Desmethylrosuvastatin

(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-methanesulfonamido-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid

C21H26FN3O6S (467.15262680000006)

N-Desmethylrosuvastatin is a metabolite of rosuvastatin. Rosuvastatin (marketed by AstraZeneca as Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. (Wikipedia)

4-Hydroxytamoxifen sulfate

{4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenyl}oxidanesulfonic acid

C26H29NO5S (467.17663440000007)

4-Hydroxytamoxifen sulfate is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

(2s,4s,5r,6r)-5-Acetamido-4-hydroxy-2-(4-methyl-2-oxo-chromen-7-yl)oxy-6-[(2r)-1,2,3-trihydroxypropyl]tetrahydropyran-2-carboxylic acid

C21H25NO11 (467.14275399999997)

10-EdAM

2-({4-[1-(4-amino-2-imino-2,3-dihydropteridin-6-yl)butan-2-yl]phenyl}formamido)pentanedioate

C22H25N7O5 (467.191708)

Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone

2-{[(benzyloxy)(hydroxy)methylidene]amino}-N-{1-[(5-fluoro-1-methoxy-1,4-dioxopentan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-3-methylbutanimidate

C22H30FN3O7 (467.2067682)

Methyl 5-[(E)-1-(3,7-dimethyl-2-oxo-1,3-benzoxazol-5-yl)-6-methoxy-6-oxohex-1-enyl]-2-methoxy-3-methylbenzoate

Methyl 5-[1-(3,7-dimethyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)-6-methoxy-6-oxohex-1-en-1-yl]-2-methoxy-3-methylbenzoic acid

C26H29NO7 (467.1943924)

N-[1'-(6-Cyano-1,2,3,4-tetrahydronaphthalen-2-yl)-4-hydroxyspiro[3,4-dihydrochromene-2,4'-piperidine]-6-yl]methanesulfonamide

N-[1-(6-Cyano-1,2,3,4-tetrahydronaphthalen-2-yl)-4-hydroxy-3,4-dihydrospiro[1-benzopyran-2,4-piperidine]-6-yl]methanesulphonamide

C25H29N3O4S (467.1878674000001)

Firuglipel

4-{5-[1-(4-cyclopropanecarbonylphenoxy)propyl]-1,2,4-oxadiazol-3-yl}-2-fluoro-N-(1-hydroxypropan-2-yl)benzene-1-carboximidate

C25H26FN3O5 (467.18563980000005)

Antibiotic K 252a

methyl 16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),7(27),8(13),9,11,20,22,24-nonaene-16-carboxylate

C27H21N3O5 (467.14811360000004)

Pelitinib

N-{4-[(3-chloro-4-fluorophenyl)imino]-3-cyano-7-ethoxy-1,4-dihydroquinolin-6-yl}-4-(dimethylamino)but-2-enimidate

C24H23ClFN5O2 (467.152422)

3-[4-(1-benzyl-3,6-dihydro-2H-pyridin-4-yl)-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one

C25H23F2N3O4 (467.1656542)

tsas#9

C23H33NO9 (467.21552080000004)

CONFIDENCE standard compound; INTERNAL_ID 93

Disaccharide(Hex-Hex) + C4H5N3O2

C16H25N3O13 (467.138732)

Annotation level-3

k-252a

Antibiotic K 252a

C27H21N3O5 (467.14811360000004)

A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors K-252a, a staurosporine analog, inhibits protein kinase, with IC50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively[1][2]. K-252a is a potent inhibitor (IC50 of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene[3].

2,18-dioxo-2,18-seco-paxilline

C27H33NO6 (467.23077580000006)

1-Nordistamycin A

C21H25N9O4 (467.202941)

YM201636

6-amino-N-[3-[4-(4-morpholinyl)pyrido[3,2:4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide

C25H21N7O3 (467.1705796)

Penigequinolones A and B (diastereomers)_120177

C27H33NO6 (467.23077580000006)

MMV687813

C25H23N3O4F2 (467.16565420000006)

Ala Cys Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]hexanoic acid

C21H33N5O5S (467.2202288000001)

Ala Cys Phe Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C20H29N5O6S (467.18384540000005)

Ala Cys Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]hexanamido]-3-phenylpropanoic acid

C21H33N5O5S (467.2202288000001)

Ala Cys Gln Phe

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-phenylpropanoic acid

C20H29N5O6S (467.18384540000005)

Ala Phe Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C21H33N5O5S (467.2202288000001)

Ala Phe Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C20H29N5O6S (467.18384540000005)

Ala Phe Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C21H33N5O5S (467.2202288000001)

Ala Phe Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C20H29N5O6S (467.18384540000005)

Ala Lys Cys Phe

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C21H33N5O5S (467.2202288000001)

Ala Lys Phe Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C21H33N5O5S (467.2202288000001)

Ala Asn Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid